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Between 1966and 1984, there were 63 children less than
5 years of age who underwent 70 valve replacements (49
mitral [5 repeat], 6 aortic, II tricuspid [systemic ven-
tricle; 2 repeat]), 2 tricuspid [pulmonary ventricle] and
1 multiple [mitral-aortic]) at Children's Hospital. Tissue
valves were used in 20%. Since 1980, only Bjork-Shiley
and St. Jude valves have been used. The most common
indication for valve replacement was mitral regurgita-
tion after repair of atrioventricular (AV) canal (34%).
Mortality dropped considerably over time: 76% be-
fore 1979,33% from 1979 to 1982 and 22% since 1982.
More than two-thirds of fatalities were operative deaths,
usually within 3 days of surgery. Actuarial survival Curves
for those operated on since 1980 predict I and 5 year
survival of 73 and 51%, respectively. For the 46 oper-
ative survivors I and 5 year valve survival was 97 and
When the experience with valve replacement at Children's
Hospital was reviewed a decade ago ( I) there were 54 chil-
dren and young adults in the series but only 4 were less
than 5 years of age. Through 1984 we have performed 70
valve replacements in 63 patients less than 5 years of age.
This increased frequency largely reflects more aggressive
management. Certain defects such as atrioventricular (AV)
canal defect or complex forms of d- or 1- transposition of
the great arteries are now repaired rather than palliated and
occasionally result in complications requiring valve replace-
ment. Moreover, with an increased number of primary valve
replacements, repeat operations are occasionally necessary,
especially if the original replacement was performed in a
small and rapidly growing child.
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70%, respectively. Postoperative hemodynamics were
significantly improved on elective postoperative cathe-
terizations.
All but one patient with nontissue valves received
anticoagulant therapy. Postoperative complications in-
cluded thromboembolism (1.6/100 patients-years) and
hemorrhage (0.8/100 patient-years). The frequency of
intravascular hemolysis and endocarditis was 1.6%,
comparable with adult experience. Complete heart block
requiring a pacemaker developed in nine patients (14.1%),
in all after AV valve replacement.
Valve replacement in young children generally results
in considerable hemodynamic improvement. The mor-
tality rate remains above that observed in adults but has
declined considerably for those operated on after 1980.
(1 Am Coil Cardiol 1986;8:901-8)
Although valve replacement in the small child is becom-
ing increasingly common, little reported information is
available concerning the risks and benefits of surgery in this
group. There are only 22 children under 5 years of age
reported in previous series of valve replacement (2-7). Be-
cause there are special considerations involved in valve re-
placement in very young children, we will review the in-
dications, results and complications of valve replacement
in this age group.
Methods
Study patients. Charts of all 63 patients under 5 years
of age undergoing valve replacement at Children's Hospital
from 1966 through 1984 were reviewed. Of the 70 valve
replacements in our series, 6 were in the aortic position, 49
in the mitral position, II in the tricuspid position (systemic
ventricle), and 2 in the tricuspid position (nonsystemic ven-
tricle); 1 was a multiple valve replacement (mitral-aortic).
These totals include seven repeat valve replacements (five
mitral and two tricuspid). One patient was lost to follow-
up. The median follow-up for operative survivors (46 pa-
tients) was 21 months (range 1 month to 12 X/12 years).
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Figure I. Actuarial surviva l curves for patient s operated on before
1980 (n = 26) and in 1980 and after (n = 37) .
following diagnoses: mitral atresia, Taussig-Bing double
outlet right ventricle and hypoplastic left heart syndrome.
The latter patient developed tricuspid (systemic) valve re-
gurgitation after a Norwood stage I procedure and required
valve replacement 7 months later.
In two children who required tricuspid valve replacement
the regurgitant valve drained into the pulmonary ventricle.
One of these children had Ebstein's anomaly and the other
had tricuspid regurgitation from pulmonary vascular disease
secondary to a ventricular septal defect.
Multiple valve and repeat valve replacement. One
child required aortic and mitral valve replacement at the age
of 2h years after having had an aortic valvotomy for critical
aortic stenosis as an infant. At operation the aortic valve
was replaced but the child could not be weaned off the
bypass pump because of severe mitral regurgitation. A par-
achute valve apparatus was found and replaced but the child
died in the operating room.
Eight children who required mitral valve replacement
before the age of 5 years later required reoperation for pros-
thetic valve stenosis. In four of the eight children the second
valve replacement occurred before age 5. The time from
the first to the second valve replacement ranged from 6
months to 12-f2 years (meanAn years).
Two children required repeat tricuspid valve replace-
ment . One had d-transposition, the other a Taussig-Bing
anomaly. In the former, reoperation was necessary 25 days
after the primary operation because of a perivalvular leak.
The other child was reoperated on I year later for prosthetic
valve stenosis due to pannus limiting valve opening.
Types of prosthetic valves. Before 1980, half the valves
inserted were tissue valves, either porcine or dura mater.
The other half were mechanical valves and were divided
between high profile (Starr-Edwards or Braunwald-Cutter)
(31 %) or low profile (69%) valves. Because of the lack of
Lesions Requiring Valve Replacement
Aortic valve replacement. Isolatedaortic valve replace-
ment was performed in six children and as part of a multiple
valve replacement in one child. The ages of these seven
children at the time of valve replacement ranged from I to
4~ years (median of 2-f2 years). In all but one patient, the
disease was congenital rather than acquired and in all seven
cases aortic regurgitation was the hemodynamic indication.
Two children, aged 2+11 and 4~ years, respectively, had
a ventricular septal defect with aortic regurgitation, and
another child, aged 2ft years, had aortic regurgitation sec-
ondary to a biscuspid aortic valve. Three patients with con-
genital aortic stenosis had an aortic valvotomy at ages I, 2
and II months, respectively, and required aortic valve re-
placement for aortic regurgitation from 17 days to 2~ years
after the valvotomy. One child with Marfan's syndrome
required aortic valve replacement for aortic regurgitation
secondary to a dilated aortic root.
Mitral valve replacement. There were 46 patients re-
quiring 50 mitral valve replacement. The total includes 44
primary isolated replacements, 5 repeat mitral valve re-
placements and I multiple (mitral-aortic) replacement. The
patients' ages ranged from 2 days to 4H years (median If!
years). Of the 50 mitral valve replacements, 38 were nec-
essary for mitral regurgitation (76%) and 12 for mitral ste-
nosis (24%).
The most common diagnosis was AV canal def ect; 20
patients had a complete defect and 4 others had a partial
defect. In 8 (33%) of these 24, the mitral valve was replaced
as part of the primary repair of the AV canal defect. Of the
24 children with a canal defect requiring valve replaceinent,
13 (54%) had Down's syndrome. Eight of the 45 children
undergoing isolated mitral valve replacement had congenital
mitral regurgitation unassociated with an AV canal defect
and without identifiable abnormality of the mitral valve.
Four of these eight chidren had associated cardiac defects
including aortic stenosis, ventricular septaldefect and coarc-
tation of the aorta. Nine other children from the entire group
had identifi able abnormalities in the formation of the mitral
valve including double orifice, parachute, redundancy with
prolapse, mitral arcade or damage after endocarditis.
Tricuspid valve replacement. Eleven children required
13 tricuspid valve replacments. In II of the operations the
valve drained into the systemic ventricle and in 2, into the
pulmonary ventricle. Four of the II had d-transposition of
the great arteries (ventricular septal defect also present in
3) and had undergone an atrial switch procedure (Mustard
procedure 2 and Senning procedure 2). Usually valve re-
placement was necessary months to years after the atrial
switch procedure. Two children with I-transposition of the
great arteries with left-sided tricuspid regurgitation required
valve replacement (in one case the native tricuspid valve
had an Ebstein' s malformation). One child had each of the
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durability of bioprosthetic valves in children reported by
this and other institutions (8-14), since 1980 mechanical
low profile valves (Bjork-Shiley or St. Jude) have been used
exclusively.
Anticoagulation. Of 46 operative survivors, 40 had me-
chanical valves and 6 had tissue valves. No patient with a
tissue valve received anticoagulant therapy. Thirty-nine of
40 patients with mechanical valves received warfarin (Cou-
madin) to keep prothrombin time between 1.5 and 2.5 times
control value. These children constituted a total experience
of 1,024 patient-months. The one child not undergoing an-
ticoagulation had a St. Jude valve in the mitral position. He
came from a country where it was impossible to regularly
measure prothrombin time.
Results
Mortality
Survival statistics for valve replacement in the 63 patients
are displayed in Figure I. By life table analysis, I year
survival was 42 ± 9.7% for those operated on before 1980
compared with 73 ± 7.7% for those operated on in 1980
and after. The 4 year survival rates were 32 ± 9.7% and
51 ± 11.4% (respectively), for the same periods. The ages
of patients from the two time periods were not significantly
different; before 1980, the mean age was 26 ± 18 months
compared with 19 ± 17 months in 1980 and after
(p > 0.05). The mean size of patients also was not signif-
icantly different: 0.47 ± 0.15 m2 before compared with
0.43 + 0.13 m2 in 1980 and after (p > 0.05). Twenty-
seven of the 29 deaths occurred in the first 2 years after
surgery; only 2 deaths occurred after 2 years. Operative
mortality was 56% before 1980 and 14% for 1980 and after.
The causes of death are summarized in Table I and discussed
in detail later.
Aortic valve replacement. Of the seven children re-
quiring aortic valve replacement six were operated on before
1980 and three died in the immediate operative period. All
three had difficulty being weaned from cardiopulmonary
bypass and had a low output state progressingto death within
the day of operation. There was one late death in a child
with Marfan's syndrome who died suddenly 3fz years after
operation; no autopsy was performed. Age at the time of
valve replacement did not predict immediate postoperative
outcome in this small group of children; the three early
deaths included both the youngest and the oldest individuals
in the series.
Mitral valve replacement. Of the 45 individuals who
have received isolated mitral valve replacement since 1976,
19 have died. Thirteen succumbed in the first month; five
of these went to the operating room on an emergency basis.
Those dying in the first week typically had difficulty being
weaned from cardiopulmonary bypass and were in low out-
put state, and either died in the operating room or soon
therafter. In five, three of whom had a high profile valve,
there was subaortic obstruction by the valve itself or by
endocardial cushion tissue. In one child with a left superior
vena cava draining to the coronary sinus, there was great
difficulty going on cardiopulmonary bypass when the left
vena cava was found unexpectedly.
Four patients died J to 6 months after surgery, Two had
an infectious illness (one of which was Clostridium colitis)
but death was not directly related to valve failure. In two,
the cause of death was unidentified.
Two patients died more than 6 months after surgery and
both deaths were related to infection. One child with a
Bjork-Shiley valve presented with Salmonella gastroenter-
itis and septicemia. Several examinations of the prosthetic
valve with ultrasound (both by imaging and Doppler study)
showed no evidence of valve dysfunction or vegetations.
The patient died of multisystem failure. Another late death
was in a 4t year old who, after a 10 day febrile illness,
suddenly became unresponsive and died. At autopsy a veg-
etation was noted at the foramen ovale as well as another
vegetation with thrombus on the prosthetic valve.
Tricuspid valve replacement. Among those whose
prosthetic tricuspid valve opened to the systemic ventricle
(II patients), there were five deaths. Three patients could
not be weaned from cardiopulmonary bypass. One of these
children with severe tricuspid (systemic AV valve) regur-
gitation and d-transposition went to the operating room crit-
ically ill after repeated cardiac arrests. One other child, also
extremely ill, required reoperation and died after pannus
prevented a valve leaflet of his no. 23 St. Jude prosthesis
from fully closing. A child with d-transposition was weaned
from bypass but died when the valve opening was restricted
by a muscular ridge related to the crista. There was one late
death in a child with hypoplastic left heart syndrome. He
presented 1-1'2 years after valve replacement with a febrile
gastointestinal illness and while hospitalized for rehydra-
tion, died suddenly for unexplained reasons.
One of the two patients whose .,nonsystemic' tricuspid
valve was replaced died. Replacement was attempted in a
14 day old with severe Ebstein's anomaly with tricuspid
stenosis. The child died in the operating room and at autopsy
had right ventricular infarction secondary to a suture placed
in the right coronary artery.
Valve Survival
Actuarial valve survival curves for operative (I month)
survivors are displayed in Figure 2. A I year valve survival
rate of 97 ± 2.6% and 5 year rate of 70 ± 18.2% are
predicted. Ten valves required repeat replacement
(Table 2). The mean time to repeat valve replacement was
3~ years (range I month to 12-1'2 years) and the mean change
in patients body surface area was 73% (range 3% to 179%).
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Table l. Cause of Death by Diagnosis in 29 Patients
Age at operation
Valve Position:
Size-Type
Time from
Operation
Operative (21)
Unable to wean from bypass (II)
Cause not identified (6)
VSD/AR
AS/valvotomy
AS/valvotomy/MS
Marfan 's/MVPIASD
Mitral atresia/HLHS
palliation
Taussig-Bing/TVR
Subaortic obstruction (3)
Partial canal
Congenital MS/coarctation
Partial canal
Preoperative arrests (I)
d-TGA/Mustard
Coronary artery suture ( I )
Ebstein anomaly
Subaortic obstruction (2)
AV canal
AV canal
Residual VSD (2)
CAVClPDA
CAVC
Pulmonary vascular disease (I)
CAVC
Difficulty going on bypass (I)
CA VCI(L)SVC to CS
Valve motion obstructed (I)
d-TGA/Mustard
Candidemia ( I)
Congenital MR
Cause not identified (2)
CAVC
CAVC
Latc on
Overwhelming sepsis (2)
Salmonella
ToF/CAVC
Clostridium
CA VClHirshprungs
Endocarditis/thrombus (I)
Congenital MR/coarctation
Unexplained (5)
Associated infection
CAVC
HLHS
Other
Marfan's/AR
AS/MS/valvotomy
ToF/CAVC
4,72 yr Ao: 19-BS o Days
If:, yr Ao: 14-DM o Days
212 yr Ao: 14-DM + () Days
Mi: 19-Hancock
f11 yr Mi: 19-Hancock () Days
2~ yr Tr(S): 23-SJ o Days
Itt yr Tr(S): 23-BS o Days
31'2 yr Mi: I-KS o Days
ft yr Mi: O-Starr o Days
h"2 yr Mi: 17-BS o Days
2f:, yr Tr(S): 23-BS o Days
14 days Tr(P): 21-SJ o Days
H yr Mi: 17-BS 5 Days
1, yr Mi: 12-DM I Day
lit yr Mi: 2l-BS I Day
2,'~ yr Mi: 17-BS I Day
,~ yr Mi: 16-DM 3 Days
41\ yr Mi: 27-Hancock 2 Days
I,":, yr Tr(S): 23-BS I Day
2 days Mi: 16-DM 9 Days
I fl yr Mi: 21-SJ 6 Days
,72 yr Mi: 19-5J o Days
3i~ yr Mi: 19-BS 2.'; yr
H yr Mi: 21-SJ /:! yr
412 yr Mi: 25-Hancock 1,"2 yr
T~ yr Mi: 17-BS .,"2 yr
j~ yr Tr(S): 25-SJ 1'"2 yr
3?2 yr Ao: IO-SE 3."2 yr
..~ yr Mi: 19-5J .,"2 yr
If, yr Mi: 17-BS ,'2 yr
Ao = aortic: AR = aortic regurgitation; AS = aortic stenosis; ASD atrial septal defect: AV = atrioventricular: BS Bjork-Shiley: CAVC
complete atrioventricular canal; CS = coronary sinus: OM = dura mater; d-TGA = d-transposition of the great arteries; HLHS = hypoplastic left heart
syndrome: KS = Kay-Shiley: (L)SVC = left superior vena cava to coronary sinus; Mi = mitral; MR = mitral regurgitation; MS = mitral stenosis;
MVP = mitral valve prolapse: PDA = patient ductus arteriosus; SJ = St. Jude: ToF = tetralogy of Fallot: Tr(P) = tricuspid-pulmonary; Tr(S) =
tricuspid-systemic; TVR = tricuspid valve replacement: VSD = ventricular septal defect.
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Figure 2. Actuarial valve survival curve for operative (I month)
survivors from 1976 through 1984 (n = 46).
Hemodynamics
Because the patients were not routinely recatheterized
postoperatively, the data are biased toward those patients
thought to have problems.
Aortic valve. Of the three survivors, one patient was
lost to follow-up but two were catheterized postoperatively.
Both children had valve replacement for severe aortic re-
gurgitation (one patient was status post-valvotomy) and both
replacements were performed at about 2-h years of age. The
first patient received a no. 17 Bjork-Shiley valve. Postop-
erative catheterization 2 years later showed a peak systolic
ejection gradient of 50 to 55 mm and a valvular index of
1.2 cmvrrr' and no aortic regurgitation. The other patient
received a Braunwald-Cutter valve and was lost to follow-
up and not restudied until 9 years postoperatively. At that
time he was asymptomatic but had a peak systolic gradient
of 85 mm Hg (with a cardiac index of 8.5 liters/min per
rrr') and mild aortic regurgitation.
Mitral valve. Nine patients had mitral valve replacement
with a low profile prosthesis, survived at least 6 months and
had follow-up catheterization. All nine had moderate to
severe regurgitation on preoperative angiograms. Their
hemodynamic states are summarized in Table 3. Postop-
erative study demonstrated trivial or no mitral regurgitation
with a return of ventricular volume to normal. If the one
patient summarized in Table 3 who was not catheterized
electively (and was thought clinically to have prosthetic
valve stenosis) is excluded, the mean (n = 8) valve gradient
was 3.9 mm rather than 5 mm.
Tricuspid valve. One additional patient with l-trans-
position of the great arteries underwent catheterization 2
years postoperatively. There was a 3 mm Hg gradient be-
tween the mean wedge pressure and the right ventricular
end-diastolic pressure and only trivial to mild prosthetic
6543
Years Postoperatively
6 1 11/2 2
mos.
Three of the 10 patients presented for reoperation acutely
(symptoms of less than I month duration).
In the 8 of the 10 patients with a mitral valve prosthesis,
the mean time to replacement was 4-n- years (range 6 months
to 12ft years). The only child presenting acutely had a no.
17 Bjork-Shiley valve implanted at the age of 4 months that
failed 6 months later from pannus limiting valve opening.
He was one of two patients whose valve was placed in the
supraanular position, The other seven patients presented
with symptoms of congestive failure of at least 2 months
duration and valve replacement was undertaken on an elec-
tive basis. Both children requiring repeat tricuspid valve
replacement presented acutely and were reoperated on 25
days and 13 months, respectively, after the initial replace-
ment.
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Table 2. Repeat Valve Replacement in 10 Patients
Initial Replacement Time from Repeat Valve Replacement
initial
replacement
Diagnosis Age (yr) BSA (nr') Valve (yr) BSA (rrr') BSA (%) Valve Indicationt
CAVC s 0.36 16-Dura mater Ii\ 0.43 19 17-BS PMSIVSD12
Congenital MR 4 0.28 17-BS 5f" 0.65 132 21-SJ PMS growth pannust12
AS/MR 5 0.35 17-BS 2t'~ 0.60 71 23-SJ PMS growthf12
Congenital MR 4,\ 0.53 5-KS 12t"2 1.48 179 27-SJ PMS growth
Mitral arcarde II 0.36 17-BS 6H 0.78 117 21-SJ PMS pannus12"
SBE* 4 0.30 17-BS " 0.40 33 21-SJ PMS pannus12 12
CAVC It":, 0.42 21-Hancock 4-Pi 0.67 60 23-BS PMS calcification
Mitral arcade 2 0.26 17-BS I~ 0.45 73 17-BS PMS pannus12
d-TGAIVSD* "L 0.35 23-SJ I 0.36 3 23-BS PTR Perivalvular leak12 12
Taussig-Bing* H 0.41 23-SJ In 0.59 44 23-BS PTR pannus trapping poppet
*Acute presentation (symptoms < I month in duration). tHemodynamic indication and its cause. [Valve orifice or motion was limited by pannus.
§Replacement necessary from patient growth resulting in a relative inadequate orifice area. BSA == body surface area; PMS == prosthetic mitral stenosis;
PTR == prosthetic tricuspid regurgitation; SBE == subacute bacterial endocarditis; other abbreviations as in Table I.
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Table 3. Hemodynamic Variables for Nine 6 Month Survivors of Mitral Valve Replacement for
Mitral Regurgitation
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LVEDP (rnm Hg)
PC-L VEDP (rnrn Hg)
End-diastolic volume (ml/m:')
Ejection fraction (%)
Regurgitation fraction (%)
Preoperative
15.6 ± 9.4*
4.9 ± 5.6
138 ± 99
0.63 ± 0.09
0.63 ± 0.09*
Postoperative
7.3 ± 2.4*
s.o ± 3.8
61 ± 17
n.64 ± n.08
-0.15 ± n.33t
Includes nine patients with a low profile prosthesis who had postoperative catheterization. *p < 0.05.
tCalculated with standard technique for calculating regurgitant fraction comparing angiographic output with
output measured using Fick principle. Mean negative regurgitant fraction reflects error in measurement technique.
LVEDP-Ieft ventricular end-diastolic pressure: PC-L VEDP = gradient from pulmonary wedge pressure to left
ventricular end-diastolic pressure.
valve regurgitation. This patient's body surface area almost
doubled over this interval.
Complications
Complications of prosthetic valves included endocarditis,
perivalvular leak, thromboembolic and hemorrhagic events,
postperfusion and postpericardiotomy syndromes and me-
chanical valve failure. The total patient experience for this
series was 1,024 patient-months.
Thromboembolism. The incidence of thromboembolic
events was 1.6 episodes per 100 patient-years and involved
two patients. In a 412 year old patient with congenital mitral
regurgitation, a thrombus on the prosthesis was found at
autopsy along with sterile vegetations. This child had had
a Hancock valve placed at If2 years of age and was not
receiving anticoagulant therapy. He died after a cerebro-
vascular accident. A If2 year old girl who underwent mitral
valve replacement using a No. 17 Bjork-Shiley valve de-
veloped a dense hemiparesis (37 days after operation) thought
to be secondary to a thrombotic cerebral vascular accident.
At the time, the patient was anticoagulated with a prothrom-
bin time approximately twice control. Ultrasound exami-
nation disclosed no valve dysfunction or thrombosis.
Bleeding. Only one child in the series had a bleeding
complication: a 3 year old girl with Marian's syndrome and
a Starr-Edwards valve in the aortic position was taking war-
farin and had numerous small ecchymoses. The hemor-
rhages may have been related to her underlying Marfarr's
syndrome because the prothrombin time was not excessively
elevated.
Of the II patients whose prothrombin time was checked
regularly at this hospital, only 64% had a prothrombin time
between 1.5 and 2.5 times, the control level on at least 50%
of the measurements. In most patients their prothrombin
time was checked by their local physician, and sufficient
results were not available to us to determine the efficacy of
their treatment.
Infection. Our policy was to administer a single dose
of antibiotic preoperatively and to continue it postopera-
tively for 48 hours (15). Five children with a prosthetic
valve had infectious complications. A 9 month old with a
Staphylococcus aureus wound infection had the only early
postoperative wound complication in the series. A 4 year
old child with a Hancock valve (see Thromboembolism)
died from complications of a cerebrovascular accident and
at autopsy had sterile vegetations on the foramen ovale as
well as thrombus and vegetation on the prosthesis. Three
children had major septic events without evidence of pros-
thetic valve dysfunction: one child had Salmonella enteritis
and septicemia; an II day old infant died with Candida
sepsis and meningitis 9 days after receiving a dura mater
valve for congenital mitral regurgitation; and an II month
old infant died of Clostridium colitis 2 months after mitral
valve replacement. The incidence of endocarditis was 1.6%
if the child with sterile vegetations is considered to have
had endocarditis.
Complete heart block. Nine children (14.1 %) devel-
oped complete heart block and required pacemaker insertion
after prosthetic valve replacement, and in all cases this oc-
curred after mitral or tricuspid valve replacement. The in-
cidence was 5. I% when valve replacement was part of the
original intracardiac operation but 22% when it was part of
a later repair. Two of the nine children with a pacemaker
died suddenly, although pacemaker dysfunction was not
established. Six of the nine had a complete AV canal defect
(in one the canal defect occurred together with tetralogy of
Fallot). The diagnoses in the other three children were coarc-
tation of the aorta with congenital mitral regurgitation, hy-
poplastic left heart syndrome, and d-transposition (with a
ventricular septal defect of the AV canal type). Thirty per-
cent of those with complete AV canal defect who required
valve replacement developed complete heart block.
Other events. Only one child had significant intravas-
cular hemolysis necessitating reoperation, although it was
not unusual to find laboratory evidence of low grade hem-
JACC Vo!. 8. No.4
October 1986:90 I-~
SPEVAK ET AL.
VALVE REPLACEMENT IN YOUNG CHILDREN
907
olysis. Four children had evidence of perivalvular leak. In
two patients, both with an aortic valve prosthesis, the leak
was minor and no significant hemodynamic complication
ensued. In one child with a tricuspid valve prosthesis, a
perivalvular leak into the area near the coronary sinus ne-
cessitated reoperation 25 days after primary repair. Another
child with a prosthetic mitral valve developed congestive
heart failure from a perivalvular leak and a reoperation was
necessary I month after the primary repair.
Discussion
Results have improved considerably for valve replace-
ments performed since 1980, which constitute the vast ma-
jority of replacements in the series (90%). One year mor-
tality decreased from 58% before 1980 to 27% for 1980 and
after. The decrease was largely due to improved operative
mortality, which declined from 54 to 14% for the same
periods. Because 21 (72%) of 29 of deaths in the entire
series occurred in the first month after operation, the marked
fall in operative mortality had a major impact on overall
patient survival.
Operative mortality. The fall in operative mortality
over time was not due to changes in patient size or age.
Part of the improvement in operative mortality was probably
related to the increased use of low profile mechanical valves
in mitral valve replacements, particulary in AV canal le-
sions. In the latter, the level of the AV valve anulus is
displaced apically so that the ratio of the left ventricular
outflow to inflow dimension is less than normal ( 16-18) . We
think that the incidence of subaortic obstruction after mitral
valve replacement fell in part because of the increased use
of low profile valves (that extended less into an already
small left ventricular outflow tract). Of operative deaths for
the entire period, 24% were related to subaortic obstruction.
Even more important, we believe that there was a learning
curve for both the surgeons and the cardiologists involved
in the operative and perioperative care. Although it is dif-
ficult to quantitate, the improved care undoubtedly contrib-
uted to the lower overall mortality.
Late outcome. There was not a commensurate fall in
late mortality. Late deaths were often related to infectious
illnesses but even when due entirely to valve failure, they
presented in a manner mimicking sepsis. We have been
impressed in both the very young infant and the older child
that the presentation of valve failure often quite closely
resembles infectious illness. When children with a prosthetic
valve present to our hospital with a febrile or respiratory
illness, we consider valve dysfunction in the differential
diagnosis. In some cases valve failure occurs as part of an
infectious illness and the failure is precipitated or exacer-
bated by the intercurrent illness, whereas in other cases, the
symptoms of valve failure mimic those of an infectious
illness with low output state causing fever.
Complication rates compared favorably with those of
other series for adults and older children (19-21). Despite
difficulties regulating anticoagulation, there were relatively
few thromboembolic events (1.6 episodes per 100 patient-
years) and episodes of bleeding (0.8 episodes per \00 pa-
tient-years). The relative infrequency of thrombotic events
probably represents our increased use of the Bjork-Shiley
and St. Jude prosthetic valves, which have a significantly
lower incidence of thromboembolic phenomena. Although
it is our policy to anticoagulate all children receiving a
prosthetic valve with warfarin, there are centers that have
not done so, using aspirin and dipyridzmole (Persantine)
instead (22). Although we cannot from our own experience
comment on this, we can say that the risk of anticoagulation
seems quite small.
Complete heart block was the most common complication
and generally occurred after mitral valve replacement, par-
ticularly when valve replacement was not part of the first
intracardiac surgery. This complication seems related to the
proximity of the AV node and His bundle to the area where
the left AV valve is sewn (particularly in AV canal defects).
Comparison with other reports. There are few pre-
viously published reports of valve replacement in very young
children so it is difficult to compare our experience with
that of previous series. Several groups (2-4,6,7,23) have
reported the results of valve replacement in young children,
but in their series patient numbers were small or results of
young children were not separated from those of all ages,
or both. Gardner et al.(2), reported a series that included
five patients with an aortic prosthesis implanted at 6 years
of age or younger. However, they did not discuss these
patients separately from the older children so it is impossible
to compare our results with theirs. Friedman et al., (5)
reported three cases of young children requiring mitral valve
replacement: in two cases the diagnosis was parachute mitral
valve and in the other case it was mitral insufficiency (the
valve was said to be grossly deformed). In these patients
there was usually prompt improvement after surgery. The
original prosthetic valve lasted longer than that in our series
(with a range from n to 9iz years) but this may have been
related to the older age of their patients at the time of
implantation (median of 3 years).
Conclusions. Valve replacement in the very young child
has become a much more frequent event, largely as a result
of more aggressive management. When the need for valve
replacement arises, the mortality is no longer extremely high
nor is the outcome poor. For operative survivors, 80% have
a functioning valve at 2 years and 70% at 5 years. Post-
operative hemodynamics have been favorable when elective
measurements are made. Complication rates compare fa-
vorably with previous series in older children and adults
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except for complete heart block and perivalvular leak . With
good reason , one can be optimistic as to the future of valve
replacement in the very young child results have already
improved considerably over the past decade.
We thank Gail Traylor for excell ent secretarial assistance in the preparati on
of this work and Nichola s Bakalis and Suzanne Mone for calcul ating
ventricular volumes .
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